Additional file 1: of Tcf7l1 directly regulates cardiomyocyte differentiation in embryonic stem cells

Supplemental information. (PDF 179 kb

Additional file 2: of Tcf7l1 directly regulates cardiomyocyte differentiation in embryonic stem cells

Figure S1. (A) Expression of Tcf7, Lef1, and Tcf7l2 in Tcf7l1−/− ESCs. (B) Comparison of conditional transgene expression levels to those in wildtype ESCs. In both Tet-On and Tet-Off systems, expression of transgene is within a comparable range to those in wildtype ESCs (PDF 1121 kb

Additional file 3: of Tcf7l1 directly regulates cardiomyocyte differentiation in embryonic stem cells

Figure S2. Constitutive transactivator activity of Tcf7l1 augmented mesoderm markers. (A) Western blot confirmation of ectopic Tcf7l1 expression. (B) Differential effects of Tcf7l1-VP16 and Tcf7l1-En on expression of mesendoderm genes, T and Mesp1, and cardiac transcription factor Nkx2–5. Gene expression assayed by real-time RT-PCR. N ≥ 3; *p < 0.05 versus control cells (PDF 364 kb

Supplementary Online Material

More information on the structure characterization and magnetization data of the Fe5GeTe2 flak

Photo-degradation of five neonicotinoids under different light source irradiation.

a = imidacloprid, b = acetamiprid, c = clothianidin, d = thiamethoxam, and e = dinotefuran.</p

Additional file 3 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma

Additional file 3: Supplementary Figure 1. (A) The best-fit OS-related lncRNAs were chosen by Lasso regression analysis. (B) The Lasso regression was performed with the optimal value of λ. (C-D) Distribution of risk scores, survival status. Supplementary Figure 2. (A-D) PCA among all genes, immune genes, immune LncRNA, and risk immune LncRNA

Image2_Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.TIF

Background: In recent years, immunotherapy has changed the therapeutic landscape of hepatocellular carcinoma (HCC). Since the efficacy of immunotherapy is closely related to the tumor microenvironment (TME), in this study, we constructed a prognostic model based on TME to predict the prognosis and immunotherapy effect of HCC patients.Methods: Transcriptome and follow-up data of 374 HCC patients were acquired from the TCGA Cancer Genome Atlas (TCGA) database. The immune/stromal/estimate scores (TME scores) and tumor purity were calculated using the ESTIMATE algorithm and the module most associated with TME scores were screened by the weighted gene co-expression network analysis (WGCNA). A TME score-related prognostic model was constructed and patients were divided into a high-risk group and a low-risk group. Kaplan-Meier survival curves and receiver operator characteristic curve (ROC) were used to evaluate the performance of the TME risk prognostic model and validated with the external database International Cancer Genome Consortium (ICGC) cohort. Combined with clinicopathologic factors, a prognostic nomogram was established. The nomogram’s ability to predict prognosis was assessed by ROC, calibration curve, and the decision curve analysis (DCA). Gene Set Enrichment Analyses (GSEA) were conducted to explore the underlying biological functions and pathways of this risk signature. Moreover, the possible correlation of risk signature with TME immune cell infiltration, immune checkpoint inhibitor (ICI) treatment response, single-nucleotide polymorphisms (SNPs), and drug sensitivity were assessed. Finally, real-time PCR was used to verify the gene expression levels in normal liver cells and cancer cells.Results: KM survival analysis results indicated that high immune/stromal/estimate score groups were closely associated with a better prognosis, while the tumor purity showed a reverse trend (p Conclusion: It provided a theoretical basis for predicting the prognosis and personalized treatment of patients with HCC.</p

Photo-degradation of five neonicotinoids in water of different quality.

a = imidacloprid, b = acetamiprid, c = clothianidin, d = thiamethoxam, and e = dinotefuran.</p

DataSheet1_Identification and Validation of a Novel Tumor Microenvironment-Related Prognostic Signature of Patients With Hepatocellular Carcinoma.ZIP

Background: In recent years, immunotherapy has changed the therapeutic landscape of hepatocellular carcinoma (HCC). Since the efficacy of immunotherapy is closely related to the tumor microenvironment (TME), in this study, we constructed a prognostic model based on TME to predict the prognosis and immunotherapy effect of HCC patients.Methods: Transcriptome and follow-up data of 374 HCC patients were acquired from the TCGA Cancer Genome Atlas (TCGA) database. The immune/stromal/estimate scores (TME scores) and tumor purity were calculated using the ESTIMATE algorithm and the module most associated with TME scores were screened by the weighted gene co-expression network analysis (WGCNA). A TME score-related prognostic model was constructed and patients were divided into a high-risk group and a low-risk group. Kaplan-Meier survival curves and receiver operator characteristic curve (ROC) were used to evaluate the performance of the TME risk prognostic model and validated with the external database International Cancer Genome Consortium (ICGC) cohort. Combined with clinicopathologic factors, a prognostic nomogram was established. The nomogram’s ability to predict prognosis was assessed by ROC, calibration curve, and the decision curve analysis (DCA). Gene Set Enrichment Analyses (GSEA) were conducted to explore the underlying biological functions and pathways of this risk signature. Moreover, the possible correlation of risk signature with TME immune cell infiltration, immune checkpoint inhibitor (ICI) treatment response, single-nucleotide polymorphisms (SNPs), and drug sensitivity were assessed. Finally, real-time PCR was used to verify the gene expression levels in normal liver cells and cancer cells.Results: KM survival analysis results indicated that high immune/stromal/estimate score groups were closely associated with a better prognosis, while the tumor purity showed a reverse trend (p Conclusion: It provided a theoretical basis for predicting the prognosis and personalized treatment of patients with HCC.</p

The structures of five neonicotinoids.

The structures of five neonicotinoids.</p